A major challenge in quantitative biological Raman spectroscopy, particularly as applied to transcutaneous Raman spectroscopy measurements, is overcoming the deleterious effects of scattering and absorption (turbidity). The Raman spectral information is distorted by multiple scattering and absorption events in the surrounding medium, thereby diminishing the prediction capability of the calibration model. To account for these distortions, we present a novel analytical method, that we call turbidity-corrected Raman spectroscopy (TCRS), which is based on the photon migration approach and employs alternate acquisition of diffuse reflectance and Raman spectra. We demonstrate that, upon application of TCRS, the widely varying Raman spectra observed from a set of tissue phantoms having the same concentration of Raman scatterers but different turbidities has a tendency to collapse onto a single spectral profile. Furthermore, in a prospective study that employs physical tissue models with varying turbidities and randomized concentrations of Raman scatterers and interfering agents, a 20% reduction in prediction error is obtained by applying the turbidity correction procedure to the observed Raman spectra.
A major challenge in quantitative biological Raman spectroscopy, particularly as applied to transcutaneous Raman spectroscopy measurements, is overcoming the deleterious effects of scattering and absorption (turbidity). The Raman spectral information is distorted by multiple scattering and absorption events in the surrounding medium, thereby diminishing the prediction capability of the calibration model. To account for these distortions, we present a novel analytical method, that we call turbidity-corrected Raman spectroscopy (TCRS), which is based on the photon migration approach and employs alternate acquisition of diffuse reflectance and Raman spectra. We demonstrate that, upon application of TCRS, the widely varying Raman spectra observed from a set of tissue phantoms having the same concentration of Raman scatterers but different turbidities has a tendency to collapse onto a single spectral profile. Furthermore, in a prospective study that employs physical tissue models with varying turbidities and randomized concentrations of Raman scatterers and interfering agents, a 20% reduction in prediction error is obtained by applying the turbidity correction procedure to the observed Raman spectra.
Blood analytes provide valuable information for the diagnosis of many diseases and related health conditions. The development of painless, noninvasive methods to measure such analytes has been extensively investigated, especially for blood glucose detection (excellent reviews can be found in the literature 1, 2 ). This area has received considerable attention, because the diagnosis and therapeutic monitoring of diabetes necessitates direct measurement of blood glucose.
3,4 A noninvasive method for measuring blood glucose levels would be an important advance, given the large number of diabetics, some of whom must undergo glucose testing several times each day. Near-infrared (NIR) Raman spectroscopy, which combines the substantial penetration depth of NIR light with the excellent chemical specificity of Raman spectroscopy, offers a promising solution for noninvasive detection of blood glucose and other analytes.
Several research groups, including our own, have reported Raman-spectroscopy-based glucose predictions at physiologically relevant concentrations in serum, 5 whole blood, 6 and other in vitro samples, such as human eye aqueous humor. 7, 8 Promising studies in transcutaneous Raman spectroscopy in human volunteers have also been conducted. 9 ,10 However, prospective application has proven to be challenging, particularly when the calibration model that has been developed on one subject is applied to a different subject. We attribute much of the difficulty in implementing successful prospective prediction methods to variations in tissue optical properties characteristic of a human subject population. Variations in turbidity, which is defined as the combined effects of scattering and absorption, alter the tissue sampling volume, diminishing the concentration prediction accuracy on prospective samples. Turbidity also results in intensity and shape distortions in the Raman spectra and introduces nonanalyte specific variance into the calibration model that deteriorates the prediction capability. Overcoming the effects of optical property variations is one of the central challenges in quantitative biological Raman spectroscopy. In other words, to accurately predict blood analyte concentrations in a group of human subjects, a methodology for extracting intrinsic (true) line shape and intensity information from the observed Raman spectra is needed.
One approach developed to reduce the aforementioned effects of the variations in optical properties on the prediction capability of the regression model was presented by Chaiken et al. 11 They conducted an in vivo study that used tissue modulation on the fingertip. Although reasonable glucose measurement accuracy was reported, the results showed that differences among individuals added significant error to the actual concentration estimates.
The necessity for correcting for variations in turbidity is widely acknowledged in the noninvasive glucose detection literature, especially NIR absorption spectroscopy. 1,2,12,13 Over the past decade, researchers in the field of fluorescence spectroscopy have also extensively studied the effects of turbid media on the observed fluorescence spectra. 14, 15 Correction schemes using a variety of experimental and analytical approaches have been developed to remove distortions induced in the fluorescence spectra due to multiple scattering and absorption. [16] [17] [18] [19] [20] [21] [22] [23] [24] For example, our laboratory has developed intrinsic fluorescence extraction methodologies using diffuse reflectance spectroscopy, based on the principle that fluorescent and diffusely reflected photons undergo similar scattering and absorption events in the turbid medium. 16, 17 While methods for extracting intrinsic fluorescence have been widely employed, only a small amount of work has been done to develop an analogous methodology for Raman spectroscopy. In one such scheme, which was used to study powder samples, the Raman signal was related to the measured diffuse reflectance as a function of the Kubelka-Munk absorption or scattering coefficients. 25 However, the Kubelka-Munk formulation, which assumes that elastic scattering is isotropic, cannot be readily extended to biological tissues, where scattering is highly anisotropic. 26, 27 Aarnoutse et al. 28 have also reported a method using simultaneous absorption measurements to correct for the absorbance of Raman scattered light by the media in catalysis reactions. In this method, only the effect of variations in sample absorption was considered, whereas in biological tissues variations in scattering are substantially more important. 29, 30 Matousek et al. have proposed a novel method for retrieving Raman spectra from subsurface layers in diffusely scattering media, which is based on the idea of collecting of Raman scattered light from surface regions laterally offset away from the excitation laser spot. 31 However, this method is useful for extracting depthresolved spectral information, and it is not suitable for application in samples where Raman scatterers are distributed throughout the turbid medium of interest.
Recently, our laboratory has developed a method to reduce the deleterious effects of turbidity variations in concentration predictions using Raman spectroscopy. As in the aforementioned case of fluorescence correction, this method is based on the use of diffuse reflectance at the same tissue region to correct for turbidity variations. Two of our laboratory's recent publications have presented a method (intrinsic Raman spectroscopy (IRS)) that corrects for the turbidity-induced sampling volume variations and relates the observed (sampled) concentration to the true concentration of the analyte of interest by means of a universal calibration curve. 32, 33 However, using a Monte Carlo technique (as proposed in IRS
32
) to determine a universal calibration curve has the limitation that the Raman scattering coefficients must be known accurately for the given constituents, which is a nontrivial task. In addition, for the experimental IRS technique 33 used for derivation of the calibration curve, one must create tissue phantoms with the same composition of constituents as that found in each tissue type. Because glucose forms a minute part of the total tissue Raman spectrum (as small as 0.3%), there remains substantial uncertainty regarding the prospective applicability of this calibration curve in vivo. Furthermore, it also requires explicit determination of the optical properties of the tissue site, specifically the reduced scattering coefficient (µ s ′(λ)). Prediction of blood analyte concentrations from human subjects under clinical conditions necessitates the introduction of a new method that is independent of tissue composition and geometry invariant.
Here, we present a different approach, which we call turbiditycorrected Raman spectroscopy (TCRS), that overcomes these difficulties by correcting for intensity and shape distortions in the observed Raman spectra. This approach also employs alternate acquisition of diffuse reflectance spectra and is based on the photon migration picture. In the following, we derive an analytical relation that connects the observed Raman spectrum, the diffuse reflectance spectrum, and the turbidity-corrected Raman spectrum. We then study a set of tissue phantoms that have the same concentration of Raman scatterers, but different background turbidities, and demonstrate that, upon application of TCRS, the turbidity-induced distortions in intensity and line shapes are removed, and the spectra tend to collapse onto a single spectral profile. The results show that TCRS can recover intrinsic line shape and intensity information from the acquired Raman spectrum in a turbid medium for the range of optical properties found in biological tissues. Furthermore, in a set of prospective studies that employ phantoms of varying turbidities and randomized concentrations of Raman scatterers and interfering agents, we obtain a 20% reduction in prediction error by applying the turbidity correction procedure to the observed Raman spectra. To the best of our knowledge, this is the first demonstration of enhanced prospective prediction accuracy employing turbidity-corrected Raman spectra, and it opens the pathway to improved prospective prediction accuracy in transcutaneous Raman spectroscopy.
THEORETICAL APPROACH
Turbidity-corrected Raman spectroscopy (TCRS) provides an analytical model that expresses the turbidity-corrected Raman spectrum in terms of the observed Raman and diffuse reflectance spectra. The following mathematical formulation builds on the probabilistic framework of the photon migration approach. The photon migration approach, which was first introduced by Weiss and co-workers, 34, 35 has been extensively used to quantify the diffuse reflectance and fluorescence spectra acquired from biological tissues by Wu et al. 16 and Zhang et al. 17 of our laboratory. In this approach, light propagation in a turbid medium is modeled as the ensemble average of the probabilistic photon migration paths distributed within the turbid medium and the realization probability of the full path of each individual photon, governed by the albedo a ) µ s /(µ s + µ a ), with µ s and µ a being the scattering and absorption coefficients, respectively. Mathematically, the diffuse reflectance spectrum (R) can then be expressed as
where F is the probability of a photon escaping the input face of the medium after n tissue interaction events and is related to the photon migration path through the medium. The escape probability function is characterized by the scattering phase function and the excitation-collection geometry of the system:
where g is the anisotropy coefficient and S is an instrument-specific constant that is dependent on the excitation-collection geometry. 17 The instrument parameter S must be calibrated for the system under consideration before further spectral analysis can be performed. As is evident from the aforementioned expression, S is smaller for more diffusely scattered light and has a higher value when a tighter sampling volume is investigated with the probe. Using the correspondence between Raman-scattered and diffusely reflected photons, the observed Raman spectrum can be defined as the ensemble average of the photon migration paths and the realization probability of the individual paths, which is now mediated not only by the absorption and elastic scattering coefficients but also by the Raman scattering coefficient:
where the subscripts x and m represent the Raman excitation (ν x ) and emission (ν m ) frequencies, respectively; Raman OBS is the observed Raman spectrum, h is Planck's constant, i is the position of the node at which Raman scattering occurs; I x is the excitation intensity, and µ R is the Raman scattering coefficient.
From eq 3, it can be observed that an incident photon at frequency ν x undergoes i scattering and absorption events prior to undergoing an inelastic Raman scattering event, with probability µ Rx /(µ ax + µ sx ), and then undergoes (n -i -1) further scattering and absorption events at frequency ν m before escaping from the medium. Note that the escape probability function, F ni , is also influenced by the position of the node at which Raman scattering occurs because the scattering coefficient, before and after Raman scattering, has different values at the excitation and emission frequencies. 17 Importantly, the role of photon path in the Raman scattering process can be clearly described from eq 3, and the similarity between diffuse reflectance and Raman photon paths should be noted.
The turbidity-corrected Raman spectrum, which we define as the spectrum that would be obtained if Raman scattering was the only photon interaction event in the medium, is given by
where Raman TC is the turbidity-corrected Raman spectrum; and l is the effective photon path length in the medium. Specifically, the effective photon path length in turbid tissue is a function of the absorption and scattering properties of the sample.
Relating eq 4 to eq 3 using the diffuse reflectance defined in eq 1, we obtain
where R 0 is the diffuse reflectance spectrum that would be obtained from a sample with the same scattering coefficient but zero absorption coefficient, and µ s ′ is the reduced scattering
When the absorption in the tissue is weak (i.e., µ s ′ . µ a ), eq 5 can be simplified to obtain
This approximation is valid for biological samples of interest in the NIR (700-1000 nm), where 5 cm -1 < µ s ′ < 20 cm -1 and 0.08
Equation 6 is key to implementing TCRS and is comprised of three factors: (a) the instrument-specific constant, S; (b) the sample-dependent factor (µ sx ′l) (as the optical path length through the tissue is a function of the scattering and absorption properties of the tissue themselves); and (c) the diffuse reflectance-based turbidity correction factor ((Raman OBS ) xm / (R x R m ) 1/2 ). As can be seen, this factor is dependent on the diffuse reflectance measured at both Raman excitation and emission frequencies. This accounts for the feature of Raman scattering in which a frequency shift from ν x to ν m is induced in the outgoing (Raman-scattered) photons. Before applying eq 6, we must determine the instrumentspecific constant (the first factor in eq 6) and the dependence of the average path length on the optical properties of the tissue (the second factor in eq 6). The optical properties, in turn, can be estimated by fitting the observed diffuse reflectance spectra to the model of Zonios et al. 38 It is important to note that when applying a standard partial least-squares (PLS) protocol 39 using the turbidity-corrected Raman spectra, there is no need to determine the instrument-specific constant, because it cancels out during the calibration/prediction procedure. Nevertheless, this constant is required for performing explicit multivariate calibration studies such as ordinary least-squares (OLS). 39 In the calibration study described later in this paper, we determine this constant, as well as the functional dependence of the average photon path length on the sample optical properties.
In addition, it is necessary to estimate the diffusely reflected light at the Raman excitation frequency (R x ), as all frequencies close to the laser line are cut off by the notch filter that is used to suppress the elastically scattered light. Because of the absence of any significant absorbers in biological tissue in the NIR range and the slowly varying nature of the scattering coefficient, the diffusely reflected light at the Raman emission frequency can be readily estimated by extrapolating a low-order polynomial, which provides the best fit to the observed diffuse reflectance spectrum at the excitation frequency.
EXPERIMENTAL METHODS
Instrumentation. The experimental setup used for the excitation and collection of Raman and diffuse reflectance spectra is similar to those described in our laboratory's earlier publications.
6,33
A schematic of the experimental arrangement is shown in Figure  1 . Briefly, an 830-nm external-cavity diode laser (Process Instruments) was used as the Raman excitation source to acquire the Raman spectra. The laser beam was focused onto the sample with an average power of ∼100 mW and a spot diameter of ∼1 mm. We employed a half-paraboloidal mirror (Perkin-Elmer, Inc.) as the primary collection element, the specifications of which are detailed in the work of Enejder et al. 6 In addition, a tungstenhalogen lamp (Avantes AvaLight-HAL-S) was used as a broadband source to obtain diffuse reflectance spectra from the sample. The beam diameter and average power of the broadband source at the sample were measured to be ∼1 mm and 100 µW, respectively. The tissue phantoms were held in a standard fused-silica cuvette. The sample interface was aligned to allow the specular reflection, which does not contain any analyte information, to escape through the hole in the paraboloidal mirror.
The backscattered light was collected and directed by the paraboloidal mirror toward a notch filter to suppress the excitation (Rayleigh) peak. The light was then focused using an optical fiber bundle onto the slit of a modified f/1.4 spectrograph (Kaiser Optical Systems, Inc.). A liquid-nitrogen-cooled deep depletion CCD detector (1 in. × 1 in.) (Princeton Instruments) with high quantum efficiency in the NIR range was used to acquire the spectra. The spectral resolution of the system was 8 cm -1 . The Raman and diffuse reflectance spectra were acquired alternately with an acquisition time per sample of 20 s each. Because of the large area of the CCD, the final images obtained were curved, and a curvature correction algorithm was applied before vertical binning. 40 The resultant spectra were subject to cosmic ray removal, background correction, and Savitzky-Golay smoothing algorithm. 41 The diffuse reflectance spectra were calibrated using a reference standard of 20% intralipid solution. Spectra of samples were acquired randomly, with respect to the constituents' concentrations. Spectra were collected three times over a period of one week. The acquired spectra at different times for each phantom were identical, within the shot noise variability. Therefore, we can conclude that there is no chemical activity in the created tissue phantoms.
Physical Tissue Models. Tissue phantom studies were performed to (1) calibrate the instrument, (2) validate the TCRS formalism, and (3) analyze its performance in prospective prediction. The objective of calibration study (1) was to determine the functional dependence of the second factor of eq 6 (µ sx ′l) on the optical properties of the samples, and to estimate the instrument-specific constant S (first factor of eq 6). Validation study (2) was designed to characterize the effectiveness of the TCRS methodology in correcting turbidity-induced variations in the observed Raman spectra. For both of these studies, ordinary leastsquares (OLS) regression was employed to determine the concentration of the components, especially that of the analyte of interest, because OLS provides the most accurate results when the spectra of all the analytes can be individually measured, as in this case. The spectra of the tissue model constituents, which were used in the OLS analysis, are shown in Figure 2 . Employing OLS for the calibration and validation studies ensures that the first and second factors of eq 6 are determined accurately and that the effectiveness of TCRS is analyzed in the absence of any spurious correlations that might be generated in an implicit calibration strategy.
Finally, prospective prediction study (3) was performed to quantitatively test the prospective prediction capability of TCRS. This study simulated the clinical conditions in which the Raman and diffuse reflectance spectra are being acquired from a human subject. Under such circumstances, in which the spectra (or concentrations) of all constituents are unknown a priori, an implicit calibration framework must be employed. Thus, to replicate the protocol that was followed in a clinical study, the results of the prospective prediction study were analyzed using partial leastsquares (PLS) analysis.
The tissue phantoms were prepared by pipetting glucose (Sigma Aldrich), creatinine (Sigma Aldrich), intralipid (Baxter Healthcare), India ink (Super Black India Ink, Speedball Art Products Co.), and distilled water into clean glass vials. Aliquots of these tissue models were taken in a fused-silica cuvette for spectroscopic measurements that were performed at room temperature. Between each measurement, the cuvette was washed three times with distilled water and dried. The phantoms were stored in the refrigerator at 4°C to avoid contamination.
India ink and intralipid were used as the primary absorber and scatterer to simulate tissue absorption and scattering in the NIR range. Specifically, the scattering and absorption coefficients were varied from 24 cm -1 to 130 cm -1 (at 830 nm) and 0.08 cm -1 to 1.3 cm -1 (at 830 nm), respectively, similar to the ranges observed in human biological tissue. 36, 37 The values of the anisotropy parameter used in the tissue models (g ) 0.8-0.9) 42 were chosen to be comparable to the typical g values that are observed in biological tissue. 36 Glucose and creatinine, both of which have characteristic Raman spectral profiles, functioned as the analyte of interest and spectral interfering agent, respectively. All three tissue phantom studiess(1) calibration, (2) validation, and (3) prospective predictionswere performed multiple times on different days to examine the reproducibility of the TCRS approach.
In the calibration and validation studies, 20 and 36 tissue phantoms were constructed, respectively. In these studies, the Raman scatterer (glucose) concentration was kept constant at 500 mM. The elastic scattering and absorption coefficients were varied randomly in the ranges previously mentioned. In both calibration and validation studies, creatinine was not employed, because the objective was to characterize the effectiveness of TCRS in extracting the intrinsic line shape and intensity information of glucose Raman spectrum acquired from a turbid medium.
In the prospective prediction study, 48 tissue phantoms of randomly varying turbidities were prepared with randomized concentrations of glucose and creatinine in the range of 4-30 mM. This range of glucose concentrations spans hypoglycemic to hyperglycemic levels, in excess of that typically observed in human subjects. The scattering and absorption coefficients were randomly varied over the same ranges used in the calibration and validation studies.
RESULTS AND DISCUSSION
Calibration Study. The observed Raman spectra from the 20 samples, which are used to calibrate the instrument and characterize the dependence of the average photon path length on the sample optical properties, showed a significant spread in the spectral profiles over the entire NIR wavelength region. Note that the concentration of glucose in all the samples was kept constant; therefore, the Raman spectra that would be obtained in the absence of multiple scattering and absorption would be expected to be the same for all of the samples. The resulting difference between the observed spectra and the spectra that would be expected in a clear medium can be primarily attributed to variations in turbidity over the tissue phantoms.
To quantify the spread of the observed spectra, we define a "spread index", which is evaluated as the ratio of the difference in maximum intensity (I max ) and minimum intensity (I min ) to the maximum intensity at the same specific wavelength (λ) for all spectra (spread index λ ) (I λ max -I λ min )/I λ max ). The mean spread index calculated over all wavelengths for the observed spectra from 20 tissue phantoms was determined to be 7.2%. Upon application of the diffuse reflectance-based turbidity correction factor ((Raman OBS ) xm /(R x R m ) 1/2 , the third factor in eq 6), the mean spread index was reduced to 1.62%. In other words, this reduced spread index was obtained by application of eq 6, while the first and second factors were held constant. The observed Raman spectra have a tendency to collapse onto a single spectral profile upon application of the diffuse-reflectance-based turbidity correction factor alone.
It is expected that there would be a negligible dependence of the second factor of eq 6, µ sx ′l, on the tissue optical properties, because the average photon path length is inversely proportional to the reduced scattering coefficient in a weakly absorbing medium. 43 Nevertheless, an optimization procedure was used to estimate the representative function for the average path length (for the second factor in eq 6) that minimizes the magnitude of the mean spread index for the 20 tissue phantoms. This minimization is an indicator of better spectral collapse than that obtained using the diffuse-reflectance-based turbidity correction factor alone, thereby enhancing the ability of TCRS in extracting more-precise intrinsic line shape and intensity information from the acquired spectra.
A power-law function of the absorption (µ a ) and reduced scattering coefficients (µ s ′) was chosen to represent the dependence of average photon path length on the optical properties of the turbid media. Note that, during this optimization procedure, the instrument-dependent constant S (the first factor of eq 6) was set equal to 1 and the power-law function was multiplied by a unit-dimensional constant to match the length units of the optical path length l. By varying the power-law exponents, we observed that the minimum spread index was obtained when the average path length l was set equal to (µ s ′) . This value of the minimum spread index was 1.58%, compared to the value of 1.62%, which we obtained using only the diffusereflectance-based turbidity correction factor in eq 6. The obtained weak dependence ((µ s ′)
) of this factor (µ s ′l) on the tissue optical properties is expected, as mentioned previously. Because of this weak functional form and the subsequent negligible reduction shown in the mean spread index function, we conclude that this factor is very weakly dependent on tissue optical parameters. We ignore the dependence of µ a and µ s ′ on this factor in further analysis.
To determine the instrument-specific constant S, we used the turbidity-corrected spectra (obtained after application of the third factor of eq 6), in conjunction with the Raman spectra of the tissue phantom constituents in a standard OLS protocol. The instrumentspecific constant that yielded the smallest prediction error was S ) 0.9. Once S was determined, it was held fixed for all subsequent studies.
Validation Study. The effectiveness of the TCRS formulation in prospectively extracting turbidity-free Raman information was tested on a separate set of 36 physical tissue models, in which the concentration of the primary Raman scatterer was held constant. Similar to the calibration study, we determined that the observed Raman spectra displayed appreciably different profiles (as shown in Figure 3a ), although in a clear medium, the uniform concentration of the Raman scatterer in each tissue phantom should result in the same Raman spectral profile. The mean spread index over all wavelengths for the observed Raman spectra was determined to be 8.5%. Upon application of TCRS, the observed Raman spectra of the 36 phantoms had a tendency to collapse onto one spectral profile, as observed by the reduction of the mean spread index to 3.1% (see Figure 3c) . Thus, TCRS provides an average reduction of 64% over all wavelengths and up to 93% in the glucose fingerprint region (800-1400 cm ). It is notable that this substantial reduction is made possible, in part, by the fact that TCRS is also able to correct for the turbidity-induced variations in the fluorescence in the tissue phantom, because of the fluorescent and diffusely reflected photons that undergo similar absorption and scattering events. 16, 17 Despite the significant improvement shown by the application of the TCRS methodology, the effect of absorption and scattering on Raman line shape and intensity is not completely removed.
There are two primary reasons behind the deviation from perfect coalescence observed in the spectral set here: (a) the presence of shot noise due to a large fluorescence background and (b) effects of photobleaching. We have observed that the former is of greater significance than the photobleaching effect, given the short duration of the experiments. We are currently investigating fluorescence removal techniques, such as shifted excitation Raman difference spectroscopy (SERDS), 44 to remove the fluorescence background.
In addition, OLS regression was used on the 36 phantom spectra to study the ability of TCRS to provide improved quantitative prediction capability. When the calibration model was used in conjunction with the uncorrected Raman spectra, the observed prediction error was 17.1%. In contrast, when the turbiditycorrected Raman spectra were used, the prediction error de- creased to 9.5%, which is a reduction of ∼44%. To visualize this improvement, we show the boxplot of the ratio of predicted glucose concentrations (C obs ), obtained using uncorrected and turbidity-corrected Raman spectra, respectively, to the reference glucose concentrations (C ref ) in Figure 4 . The mean value of C obs /C ref is observed to be 0.87 and 0.98 for the uncorrected and turbidity-corrected data, respectively, thereby showing that the calibration model using turbidity-corrected spectra is able to predict with a higher degree of accuracy. The standard deviation of the C obs /C ref values is determined to be 0.12 and 0.09 for the uncorrected and turbidity-corrected data, respectively, which implies that the precision (i.e., the degree of reproducibility) of the concentration predictions is 25% higher for the turbidity-corrected calibration model. Prospective Prediction Study. The third study was used to compare and contrast the prospective prediction capability of the calibration models developed using uncorrected and turbiditycorrected Raman spectra. In contrast to the calibration and intrinsic Raman studies described previously, here, the concentrations of glucose and creatinine were varied in a random manner over the 48 tissue phantoms. Creatinine was used as a spectral interfering agent to simulate an in vivo environment in which spectral interfering agents other than the analyte of interest (glucose) are present. To simulate the conditions of a clinical study, where the spectra (or concentrations) of tissue constituents are not known a priori, an implicit calibration strategy was used to analyze the results of this study. The uncorrected and turbiditycorrected Raman spectra were randomly divided into calibration and prediction sets, containing 36 and 12 tissue phantom spectra, respectively. A standard PLS calibration procedure, into which the spectra and the corresponding glucose concentrations were input, was iterated 500 times to evaluate an average value of prediction error that is expected to be obtained in a general scenario. For both the calibration models, developed using uncorrected and turbidity-corrected Raman spectra, respectively, five loading vectors were used in the PLS procedure. This was in accordance with the number of loading vectors that minimized the error in leave-one-out cross validation performed on the calibration set. Figure 5 shows the boxplot of root-mean-square error of prediction (RMSEP) values obtained for glucose concentrations using both uncorrected and TCRS-corrected data. The mean prediction errors were 5.8 mM and 4.7 mM for the uncorrected and TCRS-corrected data, respectively, thereby demonstrating an ∼20% reduction in prediction error on application of TCRS. In addition, the standard deviation of the 500 RMSEP values was reduced from 1.4 mM to 1.1 mM for the uncorrected and TCRScorrected data, respectively. As discussed in the following section, this reduction brings the standard deviation close to the theoretical limit when measurement noise is the only source of uncertainty. This prospective prediction study thus illustrates that TCRS substantially removes concentration errors associated with turbidity. This is an important step toward practical implementation of transcutaneous Raman scattering in human subjects.
Effect of Turbidity Correction on Minimum Uncertainty Measurement. As mentioned previously, in transcutaneous Raman scattering measurements, when contributions to measurement uncertainty due to turbidity (and any other spurious factors) are eliminated, measurement noise becomes the factor that limits measurement precision. We denote the limiting uncertainty in concentration estimation as ∆c. Based on the error analysis framework introduced by Lorber and Kowlaski, 45, 46 we have derived an expression which, for the kth analyte, relates ∆c k to the measurement noise (σ), the signal strength (norm) of the specific analyte (s k ), and its overlap with the other interfering constituents in the model (olf k ): 45, 46 ∆c k ) ( 
